1. Home
  2. ’ commenced today at the Kalinga Institute of Medical Sciences (KIMS) here. This trial aims to evaluate the efficacy of the indigenous tetravalent dengue vaccine developed by Panacea Biotec

Tag: ’ commenced today at the Kalinga Institute of Medical Sciences (KIMS) here. This trial aims to evaluate the efficacy of the indigenous tetravalent dengue vaccine developed by Panacea Biotec

Programme
First Dengue Vaccine Phase 3 Clinical Trial Kicks off at KIMS : Ommtv

First Dengue Vaccine Phase 3 Clinical Trial Kicks off at...

BIDYADHAR BARIK MADHU Sep 2, 2024 0 27543

First Dengue Vaccine Phase 3 Clinical Trial Kicks off at KIMS : Ommtv